Highlights of the St Gallen International Expert Consensus 2011 The St Gallen Consensus Conference focussed again this year on therapy recommendations for early breast cancer, based on evidence as well as clinical expertise, predominantly from Europe and the USA. The motto of this year’s conference was: “Strategies for subtypes. Dealing with the diversity of breast […]
International Research including UCC identified BP Genes
October 4, 2011 by Leave a Comment
Scientists from a large international academic consortium including University College Cork (UCC), have identified genetic variants associated with blood pressure in individuals of European descent. Their research provides new insights into genetics that could contribute to the treatment of high blood pressure. The findings were published last month in the prestigious journal Nature Genetics. Genetic […]
News in Cervical Cancer Diagnostics
October 4, 2011 by Leave a Comment
One to Watch Dr Fiona Lyng has been singled out as ‘one to watch’ by Enterprise Ireland for her work on cervical cancer. She is developing a cervical cancer diagnostic system in collaboration with the Radiation and Environmental Science Centre at DIT, and the Coombe Women & Infants University Hospital. At present, diagnosis depends on […]
CervicalCheck – The National Cervical Screening Programme
October 4, 2011 by Leave a Comment
The National Cancer Screening Service (NCSS) launched CervicalCheck – The National Cervical Screening Programme in September 2008. CervicalCheck provides free smear tests for women aged 25 to 60. Overview of CervicalCheck Screening is recommended every three years for women aged 25 to 44 and every five years for women aged 45 to 60, in line with best international […]
Irish University Pioneers Prostate Cancer Breakthrough
October 4, 2011 by Leave a Comment
Scientists at Queen’s University Belfast have pioneered a new combination treatment for prostate cancer. The treatment is aimed at men with an advanced and aggressive form of prostate cancer which has spread to the bone. The first of its kind to be developed, it combines traditional chemotherapy with two doses of a radioactive chemical that […]
The HPV School Immunisation Programme
October 4, 2011 by Leave a Comment
Overview of the Programme The HSE human papillomavirus (HPV) programme, which commenced in May 2010, targets: - All girls in 1st year of second level schools, - Girls in 6th year of second level schools in September 2011, 2012 and 2013. From September 2014 the programme will target all girls in 1st year of second level schools […]
Non-Prescription Cough and Cold Medicines for Young Children – New Advice
October 1, 2011 by Leave a Comment
The IMB recently informed healthcare professionals of new recommendations on the use of cough and cold medicines in children. The new advice follows a review of the safety and efficacy of these medicines in children and reflects an evolution in the therapeutic strategy over time for the management of coughs and colds in children rather […]
Lipikar Balm AP
October 1, 2011 by Leave a Comment
Company: L’Oréal Active Cosmetics. Legal category: OTC. Active ingredients: Niacinamide 4%, shea butter 20%, canola oil 5%, glycerine 10%, La Roche-Posay thermal spa water. Presentation: 200ml, €12.30; 400ml, €18.50. Indication: Atopic dermatitis eczema. Dosage: Adults and children: Apply once a day. Use on skin cleansed with a gentle, soap-free product. Information and references available from […]
European Medicines Agency recommends restricting use of Multaq
October 1, 2011 by Leave a Comment
Benefit-risk balance of anti-arrhythmic medicine remains positive in a limited population of patients with paroxysmal or persistent atrial fibrillation. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended restricting the use of Multaq. The anti-arrhythmic medicine should only be prescribed for maintaining heart rhythm in patients with paroxysmal or persistent […]
Lutein Omega 3
October 1, 2011 by Leave a Comment
Company: Meda Health Sales. Legal category: OTC. Active ingredients: Vitamin C 60mg; vitamin E 10mg; omega 3 fatty acids (DHA 50%, EPA 10%) 400mg; zinc 15mg; copper 1mg; lutein 10mg; zeaxanthin 2mg. Description: Brown coloured capsules. Presentation: 60, €13.23 (2 months supply). Indication: Nutritional supplement to promote healthy eyesight for patients with age-related macular degeneration. […]
Loading ...
